Sydney Neuroimaging Analysis Centre

Level 1, 94 Mallett Street, Camperdown, NSW 2050, Australia  All Australia companies → — Founded 2012
AI Research Lab Imaging AI Specialist Specialty-Focused AI
Neurology Radiology
Neurology AI Radiology & Imaging AI
Grant funding (accelerator program)

Products

iQ-solutions
iQ-solutions
Neurology AI
iQ-solutions™ is an AI-powered software medical device for quantitative MRI brain analysis, providing accurate and reproducible measurements of brain structures and pathology to monitor neurological disorders like Multiple Sclerosis and cognitive decline.

See all 1 product →

About Sydney Neuroimaging Analysis Centre

Sydney Neuroimaging Analysis Centre (SNAC) is a healthcare AI company that integrates advanced neuroimaging research with a regulatory-compliant commercial image analysis facility. Located within the University of Sydney’s Brain and Mind Centre, SNAC focuses on developing novel biomarkers for the diagnosis and monitoring of brain diseases and providing central MRI analysis services to the pharmaceutical industry.

SNAC utilizes cutting-edge technologies, including artificial intelligence and deep learning algorithms, to provide quantitative analysis of magnetic resonance imaging (MRI) images for pharmaceutical companies and researchers conducting Phase 2-4 clinical trials. Their AI-powered software, such as iQ-solutions and VeriScout, aims to improve productivity, enhance reporting accuracy, and rapidly identify critical imaging abnormalities in neurological conditions like multiple sclerosis and dementia. SNAC’s solutions are designed to integrate with routine clinical radiology workflows, offering tools for automated brain structure annotation, visualization, quantification, and critical abnormality detection.

Focus Areas

Neuroimaging research AI algorithms for neurological disorders imaging biomarker development central MRI analysis services for clinical trials clinical radiology workflows imaging informatics multiple sclerosis dementia cognitive decline acute intracranial hemorrhage detection

Business Intelligence

TechnologyCloud-native, deep learning, computer vision, big data analytics, federated learning, Torana™ (privacy-preserving informatics platform/medical imaging gateway), integration with PACS and RIS, AI-powered MRI analysis platform

What Physicians Need to Know

Neuroimaging Research & AI Algorithms
SNAC uniquely integrates advanced neuroimaging and AI research, developing state-of-the-art AI algorithms for neurological disorders. They focus on fundamental research to clinical practice, partnering with the University of Sydney's Brain and Mind Centre.
Imaging Biomarker Development
SNAC specializes in developing novel imaging biomarkers for the diagnosis and monitoring of brain diseases, translating this research into clinical trials for emerging therapeutics.
Central MRI Analysis for Clinical Trials
They provide comprehensive, regulatory-compliant central MRI analysis services for Phase 2-4 clinical trials, particularly for Multiple Sclerosis (MS). This includes expert advice on study design, site certification, study management, and timely reporting.
Clinical Radiology Workflows & Imaging Informatics
SNAC offers solutions to enhance the efficiency, accuracy, and robustness of medical imaging services. Their software, Torana, and consulting services help optimize custom imaging informatics systems and integrate AI into routine clinical workflows.
Multiple Sclerosis (MS) Expertise
SNAC has particular expertise in MS, redefining clinical trials for remyelinating therapies and developing AI-powered tools like iQ-solutions™ for precise monitoring of brain inflammation and atrophy.
Dementia & Cognitive Decline
They are advancing AI-powered MRI analysis platforms for dementia care, including Alzheimer's disease and mild cognitive impairment, to enable early detection and precise monitoring of disease progression.
Acute Intracranial Hemorrhage Detection
SNAC's VeriScout™ software uses deep learning AI algorithms to robustly detect and triage acute intracranial hemorrhage in CT images within seconds, integrating results directly into hospital Radiology Information Systems (RIS).
Physician Tip

For physicians, SNAC offers AI-powered tools that significantly enhance diagnostic accuracy and workflow efficiency. Their iQ-solutions™ provides quantitative analysis of brain structures from MRI scans, offering objective and reproducible data to complement radiologist reports, which is particularly beneficial for monitoring chronic neurological diseases like MS and dementia. The VeriScout™ software can rapidly detect and triage acute intracranial hemorrhage, ensuring critical cases are prioritized and speeding up diagnosis and intervention. SNAC's solutions are designed for seamless integration into existing clinical radiology workflows, minimizing disruption and maximizing utility. They also provide tailored training in neuroimaging and AI for medical professionals.

SNAC's solutions, such as iQ-solutions™ and VeriScout™, are designed for seamless integration with existing clinical systems like Picture Archiving and Communication Systems (PACS) and Radiology Information Systems (RIS). Their data informatics platform, Torana™, facilitates effortless management and routing of medical imaging data in multi-channel and vendor-neutral workflows. This allows for automated processing of scans and direct delivery of AI-evaluated results to radiologists' viewers without altering their established workflows. SNAC also collaborates with leading imaging providers like I-MED Radiology Network to deploy their AI solutions.

Products by Sydney Neuroimaging Analysis Centre

1 product in the directory

iQ-solutions
iQ-solutions
Neurology AI
iQ-solutions™ is an AI-powered software medical device for quantitative MRI brain analysis, providing accurate and reproducible measurements of brain structures and pathology to monitor neurological disorders like Multiple Sclerosis and cognitive decline.

What the Web Says

Sydney Neuroimaging Analysis Centre (SNAC) is an Australian company that develops AI tools for neuroimaging analysis, aiming to improve the diagnosis and monitoring of brain diseases. They offer services to the pharmaceutical industry and collaborate with institutions like the University of Sydney's Brain and Mind Centre. SNAC's products, such as iQ-solutions, provide quantitative analysis from MRI scans, including lesion burden and brain volumes, to assist radiologists. The company is recognized for its cutting-edge AI technology and its role in advancing neuroimaging research and clinical practice.

Overall: Positive

Strengths

  • Automates laborious analysis tasks, significantly reducing processing time for MRI images (e.g., isolating brains from head scans, segmenting brain lesions).
  • Provides more consistent and accurate results compared to manual analysis.
  • Develops AI algorithms for critical applications like flagging urgent brain scans and tracking changes in brain volume and lesions over time.
  • Offers clinically validated neuroimaging AI solutions used by major hospitals and imaging providers.
  • Collaborates with leading research institutions and industry partners.
  • Contributes to the development of novel biomarkers for diagnosis and monitoring of brain diseases.

Limitations

  • No specific negative product or employer reviews were found on G2, Glassdoor, Capterra, or Reddit.

Based on reviews from: Healthcare IT News, SOTA2, NVIDIA, ZDNET, SNAC, The University of Sydney, I-MED Radiology, MedIndexer

Last updated: 2026-10-22

Videos

News, demos, and interviews about Sydney Neuroimaging Analysis Centre.

Loading videos...

Videos load interactively. If none appear, search YouTube for Sydney Neuroimaging Analysis Centre →

View all on YouTube

Press & Coverage

GCG Global Healthcare
St Vincent's Hospital Sydney to deploy SNAC's AI diagnostic solutions
St Vincent's Hospital Sydney is partnering with Sydney Neuroimaging Analysis Centre (SNAC) to co-develop and deploy AI-driven diagnostic solutions, integrating AI engineers, radiologists, and clinicians to implement AI clinical applications in a major Australian hospital.
2026-07
SNAC
Sydney Neuroimaging Analysis Centre Secures CUREator+ Funding to Advance AI-Driven MRI Platform for Transforming Dementia Care
SNAC announced CUREator+ funding to accelerate its AI-powered MRI analysis platform for dementia care, aiming to improve early detection and monitoring of conditions like Alzheimer's disease and mild cognitive impairment.
2025-09
MobiHealthNews
Sydney Neuroimaging Analysis Centre bags grant for dementia, multiple sclerosis analysis AI | MobiHealthNews
SNAC secured A$3.75 million in government grant funding from ANDHealth+ to commercialize its AI-powered software, iQ-solutions, for analyzing and monitoring brain diseases like multiple sclerosis and dementia, following Therapeutic Goods Administration (TGA) clearance.
2024-07
The University of Sydney
AI to assist in the diagnosis of dementia - The University of Sydney
The Sydney Neuroimaging Analysis Centre (SNAC) received a boost to its AI, specifically for its iQ-Solutions product, through the ANDHealth+ program, with funding of up to $3.75 million to advance the diagnosis of dementia and other neurological disorders.
2024-07
SNAC
Sydney Neuroimaging Analysis Centre announces TGA (Class 2) approval of our flagship medical imaging-AI product, iQ- solutions | SNAC
SNAC announced that its flagship medical imaging-AI product, iQ-solutions, received Therapeutic Goods Administration (TGA) Class 2 approval for marketing in Australia, complementing its existing US FDA 510K clearance.
2024-07
SNAC
Sydney Neuroimaging Analysis Centre Receives Prestigious ANDHealth+ Program Funding
SNAC was named a recipient of the ANDHealth+ accelerator grants, receiving $3.75 million in non-dilutive funding from the Medical Research Future Fund (MRFF) to advance its AI-based software platform, iQ-Solutions, for monitoring brain diseases.
2024-07
BioSpectrum Asia
Australia invests $20 M to explore use of AI for treating brain disorders - BioSpectrum Asia
The Australian Government is investing $20 million to commercialize digital health research, with SNAC being one of six companies to share in $3.75 million in funding from the ANDHealth+ program to use AI for monitoring brain diseases like multiple sclerosis and dementia with its iQ-Solutions product.
2024-07
FDA
December 18, 2023 Sydney Neuroimaging Analysis Centre Pty Ltd Belinda Dowsett Associate Director, Medical Devices / IVD Phar
This document from the FDA confirms the 510(k) clearance for SNAC's iQ-solutions™, a software medical device for automatic annotation, visualization, and quantification of segmentable brain structures from MRI scans.
2023-12

Frequently Asked Questions

SNAC specializes in applying advanced neuroimaging techniques and AI algorithms to research various neurological disorders, including multiple sclerosis, dementia, and cognitive decline. Their focus is on developing and validating AI-driven solutions to improve diagnostic accuracy and prognostic capabilities for these conditions.
SNAC is actively involved in developing novel imaging biomarkers that can objectively measure disease progression and treatment response in neurological disorders. These biomarkers are crucial for clinical trials, providing sensitive and specific endpoints to evaluate the efficacy of new therapies and accelerate drug development.
SNAC provides comprehensive central MRI analysis services for multi-center clinical trials, ensuring standardized image acquisition, processing, and analysis. They adhere to strict quality control protocols and regulatory compliance standards to deliver reliable and robust data for trial sponsors.
SNAC possesses expertise in acute intracranial hemorrhage detection, leveraging advanced imaging analysis techniques and potentially AI algorithms to identify and quantify hemorrhages rapidly and accurately. While specific product names aren't always public, their research often translates into tools that can enhance clinical radiology workflows for urgent cases.
SNAC designs its imaging informatics solutions to seamlessly integrate with existing clinical radiology workflows, aiming to improve efficiency and reduce turnaround times. They offer support to healthcare administrators through training, technical assistance, and ongoing consultation to ensure smooth implementation and optimal utilization of their platforms.
SNAC's pricing model is typically tailored to the specific services and scope of each project, whether it's for research collaborations, clinical trial support, or specific software solutions. They often offer customizable options to accommodate the diverse needs and budgets of academic institutions, pharmaceutical companies, and healthcare providers.
SNAC frequently collaborates with leading academic institutions, pharmaceutical companies, and other healthcare organizations to advance neuroimaging research and translate findings into clinical practice. These partnerships foster innovation, facilitate access to diverse datasets, and ensure their solutions are clinically relevant and impactful.

Related Companies

Perimeter Medical Imaging AI is a medical technology company dedicated to transforming cancer surgery through the use of ultra-high-resolution, real-time, advanced imaging tools. The company’s mission is to address significant unmet medical needs in cancer surgery, particularly concerning positive margins and the resulting need for re-excisions. Their proprietary technology, including the S-Series Optical Coherence Tomography […]

SOPHiA GENETICS is a healthcare AI company that has developed a cloud-native, AI-driven SaaS platform called SOPHiA DDM™. This platform is designed to enable hospitals, clinical laboratories, academic medical centers, and biopharmaceutical companies to analyze and interpret complex genomic, radiomic, and multimodal healthcare data. The company’s mission is to democratize data-driven medicine, providing actionable insights […]

Koios Care is a neurology-focused digital medicine company based in Antwerp, Belgium, specializing in AI-powered platforms. The company aims to revolutionize the management of neurological and chronic conditions, with an initial focus on Parkinson’s Disease. Koios Care’s platform utilizes everyday devices like smartphones and smartwatches to passively collect and analyze data, transforming it into objective, […]

Qure.ai is a leading healthcare AI company that leverages deep learning and artificial intelligence to revolutionize medical imaging diagnostics and make healthcare more accessible and affordable globally. The company develops AI-powered solutions for interpreting X-rays and CT scans, addressing critical health needs in areas such as lung, musculoskeletal, cardiovascular, and neurocritical health. Their technology assists […]

Deep Bio is a healthcare AI company that develops deep learning-based cancer diagnostic support software, aiming to advance patient outcomes by empowering clinicians with innovative technology. Their mission is to provide tools that enable medical professionals to make critical decisions, ultimately enhancing healthcare delivery and allowing clinicians to focus more on patient care. The company’s […]

CortiCare is a healthcare AI company specializing in neuro telemetry and remote patient monitoring, primarily focusing on electroencephalogram (EEG) services. The company provides telehealth services and an EEG brain monitoring platform to neurology and critical care areas within hospitals, including ICUs, NICUs, PICUs, and EMUs. Their services aim to enhance the neurological assessment of adult, […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.